Trial record 1 of 1 for:    01390220
Previous Study | Return to List | Next Study

Study to Evaluate the Safety and Effectiveness of USL261 in Patients With Seizure Clusters

This study is currently recruiting participants.
Verified April 2013 by Upsher-Smith Laboratories
Sponsor:
Information provided by (Responsible Party):
Upsher-Smith Laboratories
ClinicalTrials.gov Identifier:
NCT01390220
First received: July 6, 2011
Last updated: April 16, 2013
Last verified: April 2013
  Purpose

The purpose of this study is to examine the safety and effectiveness of USL261 for the outpatient treatment of seizure clusters.


Condition Intervention Phase
Epilepsy
Drug: USL261
Drug: Placebo
Phase 3

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Primary Purpose: Treatment
Official Title: A Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Intranasal Midazolam (USL261) in the Outpatient Treatment of Subjects With Seizure Clusters

Resource links provided by NLM:


Further study details as provided by Upsher-Smith Laboratories:

Primary Outcome Measures:
  • Proportion of subjects who meet the criteria for Treatment Success. [ Designated as safety issue: No ]
    Treatment Success is defined as achieving both of the following: 1) termination of seizure(s) within 10 minutes after study drug administration, and 2) no recurrence of seizure(s) within 4 hours after study drug administration.


Secondary Outcome Measures:
  • Occurrence of seizure(s) within 6 hours after study drug administration.
  • Time to next seizure after study drug administration.
  • Frequency of seizure(s) within 6 hours after administration of study drug.

Estimated Enrollment: 155
Study Start Date: June 2011
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: USL261 Drug: USL261
Experimental: Placebo Drug: Placebo

  Eligibility

Ages Eligible for Study:   14 Years to 65 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Has a competent, adult caregiver who can recognize and observe the subject's seizure cluster episodes
  • Has an established diagnosis of partial or generalized epilepsy that includes the following:

    • A documented history of seizure clusters lasting > 10 minutes and < 6 hours, with a pattern that is observable, stereotyped, and recognizably different from the subject's other non-cluster seizure activity, if any;
    • A seizure cluster pattern composed of multiple (≥ 2) partial or generalized seizures;
    • A seizure cluster pattern established > 3 months before Visit 1;
    • A frequency of ≥ 4 seizure clusters during the year before Visit 1;
    • At least 1 seizure cluster occurring ≤ 3 months before Visit 1;
    • Seizure cluster pattern is confirmed by a central reviewer
  • Currently on a stable dosing regimen of AEDs since Visit 1 and for ≥ 7 days before Visit 2, with or without intermittent use of benzodiazepines at a constant dose

Exclusion Criteria:

  • Has a neurological disorder that is likely to progress in the next year
  • Has had psychogenic, non-epileptic seizure(s) within the 5 years before Visit 1
  • Has a history of their stereotypical seizure cluster progressing to status epilepticus within the 2 years before Visit 1 or has a history of seizure clusters progressing to status epilepticus despite therapeutic intervention
  • Have a history of acute narrow-angle glaucoma.
  • Has had an active suicidal plan/intent or active suicidal thoughts in the 6 months before Visit 1 or any lifetime suicide attempt
  • Taking felbamate for less than 18 consecutive months before Visit 1 or has discontinued felbamate within 30 days before Visit 1
  • Currently taking or has taken vigabatrin within 1 year before Visit 1
  • Taken vigabatrin in the past and has either no documentation of visual field exam or documentation on an abnormal visual field exam
  • Currently using a VNS unless the device has been implanted for at least 6 months and the setting stable for 4 weeks before Visit 1
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01390220

Contacts
Contact: Gerrit Ross 1-866-372-0526

  Hide Study Locations
Locations
United States, Arizona
United States, Arizona Recruiting
Phoenix, Arizona, United States
Contact     866-372-0526        
United States, Arizona Recruiting
Tucson, Arizona, United States
Contact     866-372-0526        
United States, Arkansas
United States, Arkansas Recruiting
Little Rock, Arkansas, United States
Contact     866-372-0526        
United States, California
United States, California Recruiting
Loma Linda, California, United States
Contact     866-372-0526        
United States, California Recruiting
Ventura, California, United States
Contact     866-372-0526        
United States, Colorado
United States, Colorado Recruiting
Aurora, Colorado, United States
Contact     866-372-0526        
United States, Connecticut
United States, Connecticut Recruiting
New Haven, Connecticut, United States
Contact     866-372-0526        
United States, Florida
United States, Florida Recruiting
Gulf Breeze, Florida, United States
Contact     866-372-0526        
United States, Florida Recruiting
Tampa, Florida, United States
Contact     866-372-0526        
United States, Florida Recruiting
Wellington, Florida, United States
Contact     866-372-0526        
United States, Idaho
United States, Idaho Recruiting
Boise, Idaho, United States
Contact     866-372-0526        
United States, Kansas
United States, Kansas Recruiting
Manhattan, Kansas, United States
Contact     866-372-0526        
United States, Maryland
United States, Maryland Recruiting
Baltimore, Maryland, United States
Contact     866-372-0526        
United States, Michigan
United States, Michigan Recruiting
Detroit, Michigan, United States
Contact     866-372-0526        
United States, Minnesota
United States, Minnesota Recruiting
St. Paul, Minnesota, United States
Contact     866-372-0526        
United States, Missouri
United States, Missouri Recruiting
Chesterfield, Missouri, United States
Contact     866-372-0526        
United States, New Jersey
United States, New Jersey Recruiting
Gibbsboro, New Jersey, United States
Contact     866-372-0526        
United States, New Jersey Recruiting
Hackensack, New Jersey, United States
Contact     866-372-0526        
United States, New Jersey Recruiting
New Brunswick, New Jersey, United States
Contact     866-372-0526        
United States, New York
United States, New York Recruiting
Albany, New York, United States
Contact     866-372-0526        
United States, New York Recruiting
Bronx, New York, United States
Contact     866-372-0526        
United States, New York Recruiting
New York, New York, United States
Contact     866-372-0526        
United States, North Carolina
United States, North Carolina Recruiting
Durham, North Carolina, United States
Contact     866-372-0526        
United States, Ohio
United States, Ohio Recruiting
Columbus, Ohio, United States
Contact     866-372-0526        
United States, Oklahoma
United States, Oklahoma Recruiting
Oklahoma City, Oklahoma, United States
Contact     866-372-0526        
United States, Oregon
United States, Oregon Recruiting
Portland, Oregon, United States
Contact     866-372-0526        
United States, Pennsylvania
United States, Pennsylvania Recruiting
Philadelphia, Pennsylvania, United States
Contact     866-372-0526        
United States, Tennessee
United States, Tennessee Recruiting
Nashville, Tennessee, United States
Contact     866-372-0526        
United States, Texas
United States, Texas Recruiting
Dallas, Texas, United States
Contact     866-372-0526        
United States, Texas Recruiting
Fort Worth, Texas, United States
Contact     866-372-0526        
United States, Wisconsin
United States, Wisconsin Recruiting
Madison, Wisconsin, United States
Contact     866-372-0526        
United States, Wisconsin Recruiting
Marshfield, Wisconsin, United States
Contact     866-372-0526        
Australia, New South Wales
Australia, New South Wales Recruiting
Chatswood, New South Wales, Australia
Contact     866-372-0526 ext 1-800-881-011        
Australia, New South Wales Recruiting
Randwick, New South Wales, Australia
Contact     866-372-0526 ext 1-800-881-011        
Australia, New South Wales Recruiting
Westmead, New South Wales, Australia
Contact     866-372-0526 ext 1-800-881-011        
Australia, Victoria
Australia, Victoria Recruiting
Fitzroy, Victoria, Australia
Contact     866-372-0526 ext 1-800-881-011        
Australia, Vctoria Recruiting
Heidelberg West, Victoria, Australia
Contact     866-372-0526 ext 1-800-881-011        
Australia, Victoria Recruiting
Parkville, Victoria, Australia
Contact     866-372-0526 ext 1-800-881-011        
Canada, Ontario
Canada, Ontario Recruiting
Toronto, Ontario, Canada
Contact     866-372-0526        
Canada, Quebec
Canada, Quebec Recruiting
Montreal, Quebec, Canada
Contact     866-372-0526        
Germany
Germany, Baden-Wurttemberg Recruiting
Freiburg, Baden-Wurttemberg, Germany
Contact     866-372-0526 ext 0-800-225-5288        
Germany, Bayern Recruiting
Erlangen, Bayern, Germany
Contact     866-372-0526 ext 0-800-225-5288        
Germany, Bayern Recruiting
Munich, Bayern, Germany
Contact     866-372-0526 ext 0-800-225-5288        
Germany, Hessen Recruiting
Marburg, Hessen, Germany
Contact     866-372-0526 ext 0-800-225-5288        
Germany, Nordrhein-Westfalen Recruiting
Bonn, Nordrhein-Westfalen, Germany
Contact     866-372-0526 ext 0-800-225-5288        
Germany, Westfalen-Lippe Recruiting
Bielefeld, Wetsfalen-Lippe, Germany
Contact     866-372-0526 ext 0-800-225-5288        
Hungary
Hungary Recruiting
Budapest, Hungary
Contact     866-372-0526        
Hungary Recruiting
Miskolc, Hungary
Contact     866-372-0526        
Hungary Recruiting
Nyiregyhaza, Hungary
Contact     866-372-0526        
Israel
Israel Recruiting
Haifa, Israel
Contact     866-372-0526 ext 1-80-949-4949        
Israel Recruiting
Holon, Israel
Contact     866-372-0526 ext 1-80-949-4949        
Israel Recruiting
Jerusalem, Israel
Contact     866-372-0526 ext 1-80-949-4949        
Israel Recruiting
Ramat Gan, Israel
Contact     866-372-0526 ext 1-80-949-4949        
Israel Recruiting
Tel Aviv, Israel
Contact     866-372-0526 ext 1-80-949-4949        
Italy
Italy, Lombardy Recruiting
Pavia, Lombardy, Italy
Contact     866-372-0526 ext 800-172-444        
New Zealand
New Zealand, Auklund Recruiting
Grafton, Auklund, New Zealand
Contact     866-372-0526 ext 1-800-881-011        
New Zealand, Canterbury Recruiting
Christchurch, Canterbury, New Zealand
Contact     866-372-0526 ext 1-800-881-011        
New Zealand, Waikato Recruiting
Hamilton, Waikato, New Zealand
Contact     866-372-0526 ext 1-800-881-011        
Poland
Poland Recruiting
Gdansk, Poland
Contact     866-372-0526        
Poland Recruiting
Katowice-Ochojec, Poland
Contact     866-372-0526        
Poland Recruiting
Krakow, Poland
Contact     866-372-0526        
Poland Recruiting
Lubin, Poland
Contact     866-372-0526        
Spain
Spain, Andalucia Recruiting
Sevilla, Andalucia, Spain
Contact     866-372-0526 ext 900-99-0011        
Spain, Catalonia Recruiting
Girona, Catalonia, Spain
Contact     866-372-0526 ext 900-99-0011        
Spain, Catalonia Recruiting
Terrassa, Catalonia, Spain
Contact     866-372-0526 ext 900-99-0011        
Spain, Madrid Recruiting
Aravaca, Madrid, Spain
Contact     866-372-0526 ext 900-99-0011        
Spain, Madrid Recruiting
Mirasierra, Madrid, Spain
Contact     866-372-0526 ext 900-99-0011        
Spain, Madrid Recruiting
Pozuelo de Alarcon, Madrid, Spain
Contact     866-372-0526 ext 900-99-0011        
Spain, Madrid Recruiting
Madrid, Spain
Contact     866-372-0526 ext 900-99-0011        
Ukraine
Ukraine, Kharkiv Recruiting
Kharkiv, Ukraine
Contact     866-372-0526 ext 0^00-11        
Ukraine, Odessa Recruiting
Odessa, Ukraine
Contact     866-372-0526 ext 0^00-11        
Ukraine, Ternopil Recruiting
Ternopil, Ukraine
Contact     866-372-0526 ext 0^00-11        
Ukraine, Vinnytsya Recruiting
Vinnytsya, Ukraine
Contact     866-372-0526 ext 0^00-11        
Sponsors and Collaborators
Upsher-Smith Laboratories
  More Information

No publications provided

Responsible Party: Upsher-Smith Laboratories
ClinicalTrials.gov Identifier: NCT01390220     History of Changes
Other Study ID Numbers: P261-401, 2011-001318-32
Study First Received: July 6, 2011
Last Updated: April 16, 2013
Health Authority: United States: Food and Drug Administration

Keywords provided by Upsher-Smith Laboratories:
Epilepsy
seizure clusters
acute repetitive seizures
rescue treatment

Additional relevant MeSH terms:
Epilepsy
Seizures
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Neurologic Manifestations
Signs and Symptoms

ClinicalTrials.gov processed this record on May 23, 2013